Harmony Biosciences Holdings, Inc. (HRMY) - Stock Prices, Stock Peers & Analysis

Home
HRMY

Company Name	Harmony Biosciences Holdings, Inc.
Symbol	HRMY
Currency	USD
Price	36.42
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	2,077,079,946
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	28.14 - 41.61
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Jeffrey M. Dayno M.D.
Website	https://www.harmonybiosciences.com

An error occurred while fetching data.

About Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc.